Abstract:To evaluate the value of radiomics for survival analysis and prediction of glioblastoma (GBM) patients treated with chemoradiation therapy (CRT). Twenty-eight newly diagnosed GBM patients who received CRT at our institution between 2008 and 2014 were retrospectively studied. In addition to demographics (age, race, gender) and clinical parameters (KPS, extent of resection, radiation therapy type, dose and status, whether concurrent temozolomide was adjusted/stopped), 255 imaging features were extracted from 3 gadolinium-enhanced T1 weighted MRIs for 2 regions of interest (ROIs) (the surgical cavity and its surrounding enhancement rim). The 3 MRIs were at post-operation, 1-month and 3-month post-CRT. For the radiomics approach, imaging features comprehensively quantified the intensity, spatial variation (texture), geometric property, and their spatial-temporal changes for the 2 ROIs. Overall survival (OS) and progression-free survival (PFS) were analyzed using univariate and multivariate analysis. Machine learning models (logistic regression (LR), support vector machine (SVM), decision tree (DT), neural network (NN)) were applied to evaluate the survival prediction capability of algorithmically selected features. The number of cases and percentage of cases predicted correctly were collected and AUC (area under the receiver operating characteristic (ROC) curve) were determined after leave-one-out cross-validation. For univariate survival analysis, 28 features (1 demographic, 2 clinical and 25 imaging) were statistically significant (P<0.05) for both OS and PFS. The types of imaging features were volumetric, intensity, geometry, texture and their spatial-temporal changes. For multivariate survival analysis, 14 of the features remained statistically significant (P<0.05) for OS and 20 features remained statistically significant (P<0.01) for PFS. When all the features were used by machine learning models to predict the survival, 24 features were algorithmically selected. High prediction accuracy of OS was achieved by using NN (96%, 27 of 28 cases were correctly predicted, AUC = 0.99), LR (93%, 26 of 28 cases were correctly predicted, AUC = 0.95) and SVM (93%, 26 of 28 cases were correctly predicted, AUC = 0.90). When predicting PFS, NN obtained the highest prediction accuracy (89%, 25 of 28 cases were correctly predicted, AUC = 0.92). In this preliminary study, radiomics approach combined with patients’ demographics and clinical parameters are promising (even MGMT status was not available) for survival analysis and prediction in GBM patients treated with CRT. To achieve more accurate predictions, advanced machine learning models should be considered.

Radiomics-Based Machine Learning with Natural Gradient Boosting for Continuous Survival Prediction in Glioblastoma

Reproducible and Interpretable Machine Learning-Based Radiomic Analysis for Overall Survival Prediction in Glioblastoma Multiforme

Multiparametric Radiogenomic Model to Predict Survival in Patients with Glioblastoma

Optimizing Glioblastoma, IDH-wildtype Treatment Outcomes : A Radiomics and Support Vector Machine -Based Approach to Overall Survival Estimation

234 Predictive Radiomics in Glioblastoma: A Machine Learning Approach for Personalized Survival Outcomes and a Novel Web Application

Radiomics for Survival Analysis and Prediction in Glioblastoma (GBM)—A Preliminary Study

Multiple Survival Outcome Prediction of Glioblastoma Patients Based on Multiparametric MRI

Predicting Overall Survival Time in Glioblastoma Patients Using Gradient Boosting Machines Algorithm and Recursive Feature Elimination Technique

Machine Learning Based on a Multiparametric and Multiregional Radiomics Signature Predicts Radiotherapeutic Response in Patients with Glioblastoma

Prediction of O-6-methylguanine-DNA methyltransferase and overall survival of the patients suffering from glioblastoma using MRI-based hybrid radiomics signatures in machine and deep learning framework

A Deep Learning Model with Radiomics Analysis Integration for Glioblastoma Post-Resection Survival Prediction

Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma

Non-Invasive Prediction of Survival Time of Midline Glioma Patients Using Machine Learning on Multiparametric MRI Radiomics Features

Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.

A Deep Learning-Based Radiomics Model for Prediction of Survival in Glioblastoma Multiforme

Comparison of Machine Learning Classifiers to Predict Patient Survival and Genetics of GBM: Towards a Standardized Model for Clinical Implementation

Nimg-79. A Radiomic-Risk Score For Survival Prediction In Glioma: A Large Multi-Institutional Retrospective Validation Study

Non‐invasive prediction of overall survival time for glioblastoma multiforme patients based on multimodal MRI radiomics

Comparison of MRI Radiomics-Based Machine Learning Survival Models in Predicting Prognosis of Glioblastoma Multiforme

Integrated MRI radiomics, tumor microenvironment, and clinical risk factors for improving survival prediction in patients with glioblastomas

Radiomics for glioblastoma survival analysis in pre-operative MRI: exploring feature robustness, class boundaries, and machine learning techniques